Daiichi Life Group, Inc.

8750.T
Insurance - Life
2026/08/24 Updated
Market Cap: $40.2B (¥6.4T)
Stock Price: $11.16 (¥1,777)
Exchange Rate: 1 USD = ¥159.24

[Daiichi Life Group] New Share Issuance under Equity Compensation Program | June 22, 2026

Daiichi Life Group announced on June 22, 2026, the issuance of 269,800 shares and 473,000 shares of new stock as part of its equity compensation program, raising approximately 130 million yen. The Board of Directors approved the introduction of the program to incentivize executives and enhance corporate value.

Importance:
Page Updated: June 22, 2026
IR Disclosure Date: June 22, 2026

Key Figures

  • Number of Shares Issued (RS): 269,800 shares
  • Number of Shares Issued (PSU): 473,000 shares
  • Total Amount Issued: Unknown

AI要約

Overview of Capital Policy

Daiichi Life Group resolved at its Board of Directors meeting on June 22, 2026, to issue new shares of restricted stock as part of its equity compensation scheme for directors. This aims to boost executive morale and promote sustained corporate growth. The issuance will total 743,800 shares, amounting to approximately 130 million yen. Details include restrictions on transfer periods, conditions for解除, and provisions for gratuitous acquisition, ensuring long-term incentives for directors through operational implementation.

Future Outlook and Impact on Shareholders

The recent issuance of new shares aims to incentivize directors’ shareholdings and enhance corporate value. The introduction of the scheme is expected to increase director motivation and sense of responsibility, contributing to long-term value creation. The issuance will result in a dilution of less than 0.1%, limiting the impact on existing shareholders. Going forward, we will ensure proper operation and transparency of the scheme to maximize shareholder value.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Life Group Inc.

Company overview · Stock price · Financial data · All IR

View company page →